DRUGS MADE IN AMERICA AC-RTS (DMAAR) Technical Analysis
NASDAQ:DMAAR
Taking everything into account, DMAAR scores 0 out of 10 in our technical rating. DMAAR's overall performance in the market is below average. Also recent evolutions are not that positive. Both the medium and short term picture give negative signs.
- The short term trend is negative, as is the long term trend. There should be more interesting stocks out there.
- 100% of all other stocks performed better in the past year than DMAAR.
- In the last month DMAAR has a been trading in the 0.04 - 0.14 range, which is quite wide. It is currently trading near the lows of this range.
- Prices have been falling strongly lately, it is better to avoid new long positions here.
- Volume is considerably higher in the last couple of days. In combination with the strong move down this is a bad signal.
The technical rating of DMAAR is bad and it also does not present a quality setup at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
0.06
When analyzing the resistance we notice one important area.
- Resistance @0.14 from a horizontal line in the daily time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | DOWN | NEGATIVE | The long term trend for DMAAR is down. |
| ChartMill Short Term Trend Indicator | DOWN | NEGATIVE | The short term trend for DMAAR is down. |
| ChartMill Relative Strength | 0 | NEGATIVE | DMAAR has a low relative strength, it was outperformed by 100% off all stocks on the market. |
| Simple Moving Average/SMA (20) | DOWN | NEGATIVE | The current price of DMAAR is below a declining SMA(20). |
| Simple Moving Average/SMA (50) | DOWN | NEGATIVE | The current price of DMAAR is below a declining SMA(50). |
| Relative Strength Index/RSI (14) | 25.96 | OVERSOLD | The low RSI value suggests DMAAR may be oversold. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 0 | NEGATIVE | The MACD value suggests DMAAR has a negative trend. |
| Stochastics (14,3) | 23.6 | NEUTRAL | The Stochastics value for DMAAR is a neutral value. |
| Average True Range in percent/ATR (20) | 31.98 | HIGH VOLATILITY | The high ATR as a percentage value for DMAAR suggests high volalility. |
| Average Directional Index/ADX (14) | 47.87 | POSITIVE | The high ADX value value for DMAAR suggests a strong trend. |
DMAAR Technicals: Chart, Performance Metrics, Trend & Indicators
NASDAQ:DMAAR (3/11/2026, 9:44:04 AM)
0.0599
0 (-0.17%)
DRUGS MADE IN AMERICA AC-RTS / DMAAR FAQ
What is the technical rating for DMAAR stock?
ChartMill assigns a technical rating of 0 / 10 to DMAAR.
What is the trend direction for DMAAR stock?
The current trend direction for DRUGS MADE IN AMERICA AC-RTS (DMAAR) is Bearish.
Can you provide the RSI signal for DRUGS MADE IN AMERICA AC-RTS?
DRUGS MADE IN AMERICA AC-RTS (DMAAR) has an RSI value of 25.9586. This indicates that the stock is currently oversold.
What is the MACD signal for DRUGS MADE IN AMERICA AC-RTS (DMAAR) stock?
The MACD indicator for DRUGS MADE IN AMERICA AC-RTS (DMAAR) has a value of -0.00372248, indicating a bearish trend.
Can you provide the short term momentum for DRUGS MADE IN AMERICA AC-RTS?
The short term momentum for DRUGS MADE IN AMERICA AC-RTS (DMAAR) is negative.